Moreover, the increased presence of CD14+CD163+ monocytes in HIV-positive pre-NHL aligns with previous studies showing altered immune profiles in individuals at higher risk for HIV-related malignancy [36,47,59]. The gene discussed is CD163; the disease is non-Hodgkin lymphoma.